Magali Soumillon
Co-Founder and CEO, Flexomics LLC
Magali Soumillon is listed as Co-Founder and CEO, Flexomics LLC. Magali is scheduled to speak at SLAS 2027 International Conference & Exhibition on 2 February 2027.
Compiled from published conference agendas; not yet confirmed by Magali. Is this you? Claim this profile.
About
Magali Soumillon, Ph.D., is co-founder and CEO of Flexomics, where she leads the development of technologies integrating live-cell phenotyping with single-cell molecular profiling. Her work spans single-cell genomics, functional cellular assays, imaging, and multimodal data integration. She developed SCRB-seq and subsequently co-founded Flexomics to create scalable approaches for connecting cellular function with molecular state in the same individual cells. Current work focuses on extending these capabilities to standard multiwell formats for integration with high-content imaging, laboratory automation, and functional screening workflows.